Jade Biosciences Inc. (JBIO)
Market Closed
16 Oct, 08:00 PM
NASDAQ (CM) NASDAQ (CM) Primary $
13. 47
-0.29
-2.1076%
$
861.17M Market Cap
- P/E Ratio
2.4% Div Yield
980,976 Volume
- Eps
$ 13.76
Previous Close 
Want to track JBIO and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Jade Biosciences Inc. (JBIO) Statistics
Valuation metrics
Market Cap 861.17M
Enterprise value 769.15M
Trailing P/E (ttm) -5.23
Forward P/E -
PEG ratio -0.02
Price/Sales (ttm) -
Price/Book (mrq) 2
Enterprise Value/Revenue -
Enterprise Value/EBITDA -4.92
Overview
Shares outstanding -
Float -
Shares short -
% Held by insiders -
% Held by institutions -
Average volume (10 days) 735.6K
Average volume (90 days) 852.34K
Price summary
52-Week low 8.36
52-Week high 28
Beta -
50-Day moving average 15.91
200-Day moving average 20.47
Dividends and splits
Forward annual dividend rate -
Forward annual dividend yield -
Trailing annual dividend rate -
Trailing annual dividend yield -
5-Year annual dividend yield -
Payout ratio -
Dividend Date 28 Apr 2025
Ex-Dividend Date 29 Apr 2025
Last split factor 1:35
Last split Date 29 Apr 2025
Financials
Fiscal year
Fiscal year ends -
Most recent quarter (mrq) -
Profitability
Profit margin -
Operating margin -
Operational effectiveness
Return on assets -0.32%
Return on equity -0.49%
Income Statement
Revenue (ttm) -
Revenue per share (ttm) -
Quarterly revenue growth (yoy) -
Gross profit (ttm) -
EBITDA -
Net income to common (ttm) -
Diluted EPS (ttm) -2.51
Quarterly earnings growth (yoy) -
Balance Sheet
Total cash (mrq) -
Total cash per share (mrq) 7.55
Total debt (mrq) -
Total Debt/Equity (mrq) 0
Current ratio (mrq) 14.93%
Book value per share (mrq) 7.21
Cash Flow
Cash flow statement -
Levered free cash flow (LFCF) -
2026 © Marketlog. All Rights Reserved.
